泌尿支架市場：規模、細分市場、份額、法規、報銷、程序、到 2033 年的預測

泌尿支架是插入泌尿道或輸尿管的聚合物或金屬管狀裝置，用於治療或預防阻止尿液從腎臟流向膀胱的阻塞。 輸尿管支架是一種專門設計的 10 至 12 英吋長的軟管，放置在輸尿管中，將尿液從腎臟引流到膀胱。

攝護腺癌、良性攝護腺增生症（BPH）、尿石症、腎結石等的盛行率逐年上升。 預計這將在預測期內推動泌尿支架置入術的需求。 越來越多的人面臨正常排尿困難，這是泌尿支架置放術需求逐年增加的主要原因之一。

本報告深入探討了全球泌尿道支架市場，包括競爭格局、SWOT 分析、至 2033 年的市場預測、COVID-19 的影響、區域和國家趨勢等。我是。

目錄

尿路支架目前市場及競爭狀況

• 對主要產業趨勢的見解
• 2015年至2033年按細分市場劃分的尿路支架市場總收入及市場前景
• 有關數量、平均售價和市場價值的詳細數據

全球、區域與國家見解

• 泌尿支架市場SWOT分析
• 泌尿支架市場的競爭動態洞察與趨勢
• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技的監管狀況

Abstract

Urinary Tract Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Nephrology and Urology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Urinary Tract Stents market for the year 2020 and beyond. Urinary tract stents are the tubular devices made either of polymers and metal which are inserted into the urinary tract or ureter to treat or prevent a blockage that prevents the flow of urine from the kidney to the bladder. A ureteral stent is specially designed a soft tube 10-12 inches in length that is placed in the ureter for draining urine from the kidney to the urinary bladder.

The increasing prevalence of prostate cancer, Benign Prostatic Hyperplasia (BPH), Urolithiasis and stone among people in the kidney has seen a staggering rise over the years. This is anticipated to propel the demand for urinary tract stenting over the forecast periods. The developing number of individuals facing difficulties in passing urine normally is one of the key reasons why the demand for urinary tract stenting is increasing throughout the years.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Urinary Tract Stents and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Urinary Tract Stents market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Urinary Tract Stents market.
• Competitive dynamics insights and trends provided for Urinary Tract Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Cook Group Inc, Becton Dickinson and Co, Olympus Corp, Coloplast A/S, Applied Medical Corporation, Allium Medical Solutions Ltd, Pnn Medical A/S, SRS Medical Systems Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

• CMO executives who must have deep understanding of the Urinary Tract Stents marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

• Understand the impact of COVID-19 on Urinary Tract Stents market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Urinary Tract Stents market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Urinary Tract Stents market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Urinary Tract Stents market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.